ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

Final Money Bill Clear On Permitting New Construction Funding

December 12, 1975

Komen Foundation Offer Fellowships

February 9, 1996